Welcome to our dedicated page for Cutera news (Ticker: CUTR), a resource for investors and traders seeking the latest updates and insights on Cutera stock.
Cutera, Inc. (symbol: CUTR) is a leading innovator in the field of medical aesthetics, specializing in the design, development, manufacturing, marketing, and servicing of energy-based aesthetic systems. Established in 1998 by experienced laser and optical engineers in Brisbane, California, Cutera has grown to become a trusted authority in face and body energy-based medical aesthetic technologies.
Cutera pioneered Nd:YAG technology and has continued to innovate, offering a premium portfolio of products that include Xeo®, truSculpt®, and excel V™. In 2014, the company expanded its product line with two significant additions: excel HR™, which provides high-speed, comfortable hair removal, and enlighten™, the industry's first system combining picosecond and nanosecond wavelengths.
With a presence in over 40 countries and direct operations in North America, France, Australia, Japan, and Hong Kong, Cutera is committed to meeting the evolving needs of the medical aesthetic community. Their solutions are designed to deliver better results, faster and safer than ever before.
The company markets its products under various trademarks, including Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis Plus, Pico-genesis, Titan, truSculpt, and Xeo. Cutera derives the majority of its revenue from the United States but maintains a strong international presence.
Recent achievements include the introduction of innovative products that have set new industry standards. Cutera's focus on research and development ensures that they remain at the forefront of the medical aesthetic technology market, continuously providing advanced solutions to practitioners worldwide.
For the latest updates and relevant information about Cutera's performance, events, and developments, stay tuned to Cutera's news section on StockTitan.
Cutera, Inc. (NASDAQ: CUTR) reported a strong financial performance for Q2 2021, with revenues of $58.6 million, a 122% increase year-over-year. Key segments included capital equipment revenue of $35.6 million (up 129%) and recurring revenue of $23.0 million (up 113%). Gross margin improved to 57.7%, a 13.6-point increase. Adjusted EBITDA rose to $6.8 million from a loss of $3.5 million last year. For 2021, Cutera projects revenue between $215 million and $221 million, reflecting a 46% to 50% increase over 2020.
Cutera, Inc. (Nasdaq: CUTR) announced it will report its second quarter 2021 financial results on August 4, 2021, after market close. Management will discuss these results in a conference call at 1:30 p.m. PT (4:30 p.m. ET) on the same day. Participants can join by calling 1-877-705-6003 (domestic) or +1-201-493-6725 (international), using Conference ID: 13721584. The call will also be accessible via a webcast on Cutera's Investor Relations website.
Cutera, Inc. (NASDAQ: CUTR) has renewed its exclusive distribution agreement with ZO Skin Health for skincare products in Japan, effective June 15, 2021, for an initial term of three years. This partnership aims to enhance the ZO skincare business while expanding Cutera's market presence in Japan. CEO Dave Mowry expressed satisfaction with the continued collaboration, emphasizing mutual growth opportunities over the next several years.
Cutera has appointed Sheila Hopkins to its Board of Directors, effective immediately. Chairman J. Daniel Plants praised her strategic capabilities, essential for Cutera's growth phase. CEO Dave Mowry expressed optimism about her commercial experience, beneficial for expanding Cutera's global operations. Hopkins has prior board experience and has held executive roles at Bausch + Lomb and Colgate-Palmolive. With her addition, Cutera aims to strengthen its position in the aesthetic systems market.
Cutera, a leader in energy-based aesthetic systems, will present at the Virtual UBS Global Healthcare Conference on May 26, 2021, at 3:00 pm ET. CEO Dave Mowry will lead the presentation, which will be available via webcast on the company's Investor Relations page. Based in Brisbane, California, Cutera has been providing innovative aesthetic solutions since 1998, enabling practitioners to deliver safe and effective treatments. For more details, visit www.cutera.com.
Cutera, Inc. (NASDAQ: CUTR) announces the resignation of President and COO Jason Richey, effective May 4, 2021, to pursue other opportunities. Richey will assist during the transition until May 31, 2021. CEO Dave Mowry will take on COO responsibilities temporarily. The company has engaged an executive search firm to find a new Chief Commercial Officer to steer growth. Both Mowry and Board Chairman J. Daniel Plants praised Richey's contributions during his tenure, highlighting his leadership during challenging times.
Cutera (NASDAQ: CUTR) reported strong financial results for Q1 2021, with revenue of $49.7 million, a 54.1% increase year-over-year. Capital equipment revenue rose 35.1% to $28.3 million, while recurring revenue surged 89.2% to $21.3 million, driven by a 324.4% increase in skincare revenue. Gross margin improved to 55.8%, and adjusted EBITDA showed a notable gain of $12.9 million year-over-year, reaching $4.6 million. The net loss decreased to $0.4 million, or $0.02 per share. Despite positive results, management remains cautious due to ongoing COVID-19 uncertainties.
Cutera, Inc. (Nasdaq: CUTR) will report its financial results for Q1 2021 after market close on May 5, 2021. The company, known for its innovative laser and energy-based aesthetic systems, will host a conference call at 1:30 p.m. PT (4:30 p.m. ET) on the same day to discuss its results. Investors can join by dialing 1-877-705-6003 (domestic) or +1-201-493-6725 (international) using Conference ID: 13719080. The call will also be accessible via webcast on Cutera’s website, with a replay available shortly after the call concludes.
Cutera, Inc. (NASDAQ: CUTR) announced a private placement of $125 million in 2.25% convertible senior notes due 2026. The notes will not bear regular interest and have an initial conversion rate equivalent to $33.18 per share. The offering is expected to close on March 9, 2021, with net proceeds estimated at $120.7 million, intended for general corporate purposes and capped call transactions. The company may redeem the notes after March 2024 if certain stock price conditions are met. The offering is aimed at enhancing liquidity and potentially funding strategic acquisitions.
FAQ
What is the current stock price of Cutera (CUTR)?
What is the market cap of Cutera (CUTR)?
What does Cutera, Inc. specialize in?
When was Cutera, Inc. established?
What are some of Cutera’s key products?
Where is Cutera, Inc. headquartered?
In how many countries does Cutera have a presence?
What technology did Cutera pioneer?
Where does Cutera derive the majority of its revenue?
What is the significance of the product excel HR™?
What is unique about the enlighten™ system?
How does Cutera stay at the forefront of the industry?
